Tosufloxacin

Tosufloxacin

Gene therapy
Clinical data
AHFS/Drugs.com	International Drug Names
ATC code	none
Physiological data
Legal status
Pharmacokinetic data
Identifiers
IUPAC name 7-(3-Aminopyrrolidin-1-yl)-1-(2,4-difluorophenyl)-6-fluoro-4-oxo-1,4-dihydro-1,8-naphthyridine-3-carboxylic acid
CAS Number	100490-36-6 Y
PubChem Template:Abbreviation	5517
ChemSpider	5316 N
UNII	GHJ553KQPS
KEGG	D02317 Y
ChEBI	CHEBI:77573 N
ChEMBL	ChEMBL273348 N
Chemical and physical data
Formula	C19H15F3N4O3
Molar mass	404.34 g/mol
3D model (JSmol)	Interactive image
SMILES NC1CCN(C1)c1nc2n(cc(C(O)=O)c(=O)c2cc1F)-c1ccc(F)cc1F
InChI InChI=1S/C19H15F3N4O3/c20-9-1-2-15(13(21)5-9)26-8-12(19(28)29)16(27)11-6-14(22)18(24-17(11)26)25-4-3-10(23)7-25/h1-2,5-6,8,10H,3-4,7,23H2,(H,28,29) N Key:WUWFMDMBOJLQIV-UHFFFAOYSA-N N
Template:XmarkY (what is this?)  (verify)

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Overview

Tosufloxacin is a fluoroquinolone antibiotic. It has a controversial safety profile in relation to other fluoroquinolones. It is associated with severe thrombocytopenia and nephritis, and hepatotoxicity. It is sold in Japan under the brand name Ozex.

See also

• Quinolones